Carrington Labs

"Carrington Laboratories, Inc. is an emerging, publicly-held, research-based biopharmaceutical company concentrating on two niches in the pharmaceutical market: 1) research, development, and commercialization of therapeutics for ulcerative colitis, cancer, and other diseases and conditions, and 2) products for the dressing and management of wounds, using naturally derived products specifically and from complex carbohydrates derived from Aloe vera L. "